Skip to main content

Select Drug Profiles

Original Research
Use Pattern and Off-Label Use of Atypical Antipsychotics in Bipolar Disorder, 1998-2002
Jeffery A. Demland, MS, Yonghua Jing, BPharm, PhD, Christina M. L. Kelton, PhD, Jeff Jianfei Guo, BPharm, PhD, Hong Li, PhD, Patricia R. Wigle, PharmD
Stakeholder Perspective
Health Plans’ Approaches to Managing Appropriate Use of Antipsychotic Drugs
by Renee Rizzo Fleming, RPh, MBA
Read More
Workplace Wellness and Disease Prevention: Focus on Chronic Obstructive Pulmonary Disease
Read More
COPD Management in a Value-Based Healthcare System
Read More
The Economic Burden of COPD in the Workplace
Read More
Perspectives
The Paradox of Public Policy Reform: Change or Continuum?
Robert E. Henry
Read More
Perspectives
Are You Kidding Me? Clinical Comparative Effectiveness or Evidence-Based Medicine
Thomas Kaye, RPh, MBA, FASHP
Read More
Practice Management
MIPPA: First Broad Changes to Medicare Part D Plan Operations
Jean D. LeMasurier, Babette Edgar, PharmD, MBA
Stakeholder Perspective
Part D under the Medicare Improvements for Patients and Providers Act of 2008
by Mark A. Newsom, MSc
Read More
Practice Management
New Legislations on Generics and Biosimilars Brewing in Congress
Dalia Buffery, MA, ABD
Read More
Original Research
ProvenCare: Geisinger’s Model for Care Transformation through Innovative Clinical Initiatives and Value Creation
Ronald A. Paulus, MD, MBA
Stakeholder Perspective
none
Read More
Perspectives
The Integrated Patient-Centered Medical Home: Tools for Transforming Our Healthcare Delivery System
Matias A. Klein
Read More
Page 239 of 244
Results 2381 - 2390 of 2438